Penrod

APRIL 1, 2024

What CMS-0057-F Means for Health Insurance Companies In January 2024, CMS finalized its interoperability and prior authorization rule that requires various healthcare insurance entities to abide by the latest electronic health information exchange and prior authorization process for clinical services.

Electronics 52

Electronics Insurance Healthcare Healthcare 52

pharmaphorum

JANUARY 17, 2023

” The combination has the potential to deliver higher accuracy in assisting with the diagnosis of a disease in a healthcare setting, or monitoring progression for a clinical trial, according to a statement on the transaction. million) to its top-line in 2023 with “considerable growth” next year.

Marketing 99

Marketing Healthcare Healthcare Patients 99

European Pharmaceutical Review

JANUARY 19, 2023

The additional support from Amgen is set to reach more than 300 diverse and community-oriented clinical investigators by 2027. It empowers partners to develop and test innovative solutions to advance health equity and improve access to quality healthcare for patients.

Food and Drug Administration 98

Food and Drug Administration Physicians Medicine Food 98

Medico Reach

DECEMBER 2, 2022

To bring effective medicines and Innovations in healthcare industry , a Clinical Research Organization or Contract Research Organization (CRO) are a must for the Biotech, Medtech, and pharma industries. billion , and by 2027, it is expected to reach around an exciting amount of 115.1 from 2022 to 2027. from 2022 to 2027.

Consulting 98

Consulting Specialization Medicine Medical 98

Pharmaceutical Technology

FEBRUARY 21, 2023

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approved the vaccine via an Emergency Use Authorisation (EUA) on December 21, 2020. In the long term, Comirnaty is expected to continue its momentum, with forecast sales up by more than 20% from 2024 to 2027. Comirnaty is the first globally approved Covid-19 vaccine.

Sales 98

Sales Government Leads Medicine 98

Impetus Digital

MARCH 15, 2024

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In addition, the global population is getting older, and more cancers of all stages will be diagnosed as a result, putting even more pressure on the healthcare system.

Recruitment 79

Recruitment Healthcare Provider Patients Healthcare 79

PM360

MAY 21, 2024

beatriz.gonzalez@teads.com BEATRIZ GONZÁLEZ CASAURRÁN Senior Global Industry Director CPG at Teads In healthcare, streaming platforms, Connected TV (CTV), and omnichannel strategies are offering a myriad of new, efficient, and effective advertising opportunities.

Media 105

Media Healthcare Healthcare Marketing 105

LEVO Health

JULY 15, 2024

billion by 2027. This growth presents a significant opportunity for healthcare organizations and businesses, but it also means the market is becoming increasingly saturated. Take Your GLP-1 Program to the Next Level The GLP-1 market presents a lucrative opportunity for healthcare organizations and businesses.

Marketing 52

Marketing Side effects Education Medical 52

PM360

DECEMBER 14, 2022

In its latest venture into the healthcare arena, Amazon is reaching out directly to the consumer via its soon-to-be-launched Amazon Clinic , a virtual health service for patients to see licensed clinicians about common medical issues. billion euros into its new facility where it is planning to hire 400 and 500 new personal by 2027.

Manufacturing 52

Manufacturing Medical Healthcare Healthcare 52

Medico Reach

FEBRUARY 8, 2023

Hence, looking closer at the future trends in pharma industry only makes sense for businesses to stay afloat in the healthcare market. Here are some more applications of AI in healthcare and pharma Medicines discovery and design can improve drastically. billion by 2027. billion in big data analytics.

Pharma 52

Pharma Medicine Marketing Prospecting 52

pharmaphorum

AUGUST 2, 2022

“ADHD has a significant impact on children and their families in Asia, and caregivers and healthcare providers are looking for innovative non-drug treatment options,” said Takeki Uehara, head of drug development and regulatory science at Shionogi. Image by Gemma Moll from Pixabay .

Marketing 85

Marketing Healthcare Provider Education Healthcare 85

PM360

APRIL 7, 2023

Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

PM360

JUNE 29, 2022

Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer. What if you scan a QR code on the box or bottle and it would trigger an approval from your healthcare provider? Walmart has recently focused on expanding its virtual healthcare presence.

Retail 97

Retail Marketing Healthcare Healthcare 97

Clarivate

OCTOBER 25, 2023

The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

pharmaphorum

JULY 26, 2022

It had expected the drug would not face biosimilar competition in Europe until at least 2027. The subcutaneous version still needs to be administered by a healthcare professional.

Competition 52

Competition Side effects Marketing Sales 52

pharmaphorum

JANUARY 16, 2023

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. Innovation will power the market. About the author.

FDA 85

FDA Healthcare Healthcare Medicine 85

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. 1 We have been improving patient affordability for over a decade, across generic and brand medications, including specialty treatments—sometimes by more than 50%.

Prescription 52

Prescription Medical Patients Distribution 52

Clarivate

SEPTEMBER 5, 2024

1: CMS obtained steep price cuts in its first round of negotiations Source: The Centers for Medicare & Medicaid Services By 2027, 20 additional drugs per year will be negotiated, including often complex and expensive physician-administered Medicare Part B drugs, such as infusible biologics.

Insurance 52

Insurance Marketing Manufacturing Prescription 52

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

European Pharmaceutical Review

MARCH 4, 2024

percent through 2027. 12 Administration of biologics: key considerations Bio-drug delivery systems are linked to the route of administration in clinics, which must be taken into consideration in clinical development, given the growing emphasis on patient-centric healthcare delivery. References 1.

Food and Drug Administration 98

Food and Drug Administration Transportation FDA Medical 98

Clarivate

AUGUST 27, 2024

With the global atrial fibrillation market at $6 billion today, that rate of growth would push it to $12 billion by mid-2027, if not sooner, with PFA accounting for about 70% of the market.

Marketing 52

Marketing Competition FDA Electronics 52

World of DTC Marketing

JUNE 4, 2021

If the trend continues at the current rate, millennial treatment costs are still projected to be close to $4,500 annually, roughly 33 percent higher than those of Generation X at a comparable age, by 2027. That’s about $375 per month. Why are we getting so obese? 1ne: We eat out — a lot.

Food 207

Food Insurance Leads Medical 207

European Pharmaceutical Review

OCTOBER 12, 2023

So, by the time the facility is operational, anticipated for 2027, it has potential to transform access for clinical phase development of cell therapies in the region. Commercially, establishment of the RNA manufacturing facility will help to attract inward investment and promote resilience and sustainable growth into UK healthcare.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

Curzon Consulting

DECEMBER 14, 2022

billion by the end of 2027. . According to Mordor Intelligence, the UK diagnostic imaging equipment market is estimated to be USD 1.1 billion in 2022 and is expected to reach USD 1.5 is 10-15%.

Insurance 52

Insurance Management Manufacturing Marketing 52

Legacy MEDSearch

JULY 24, 2023

Trial results are expected in 2027. Treatment will be delivered on an accelerated timeline—10 sessions a day, composed of 10-minute treatments of SAINT therapy with 50-minute breaks for five consecutive days. a primary investigator and the first to enroll in the OLO study at Acacia Mental Health, Sunnyvale, Calif.

Medical 52

Medical Recruitment FDA Patients 52

European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. Caroline Peachey is Editor of European Pharmaceutical Review.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Safety Pharmaceutical 105

European Pharmaceutical Review

FEBRUARY 7, 2023

Edward Turtle is a products lawyer, regulatory advisor and litigator with particular experience in the healthcare, technology and consumer product sectors. of the MDR and Article 110.4 of the IVDR for medical devices and in vitro diagnostic medical devices (IVDs).

Medical 117

Medical Government Marketing Medicine 117

Evolve Your Success

OCTOBER 31, 2023

Tune in and discover how one individual’s dedication can truly make a difference in the world of healthcare. By 2027, they are projected to be about $10 billion. Blake also reveals an exciting and groundbreaking development: closed-loop stimulation, a true game-changer in the world of spinal cord stimulation.

Engineering 52

Engineering Sales Medical sales Medical 52

Pharmaceutical Technology

APRIL 24, 2023

Zoetis, one of the world’s leading animal healthcare companies, recently partnered with Syngene to manufacture a drug substance for bedinvetmab, a first-in-class monoclonal antibody used for treating osteoarthritis in dogs. GlobalData forecasts Biologics to significantly overtake sales of small molecules by $120 billion by 2027.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Star OUTiCO

FEBRUARY 18, 2022

A Global Data survey reports that 35% of pharma professionals think that the pandemic increased the speed of digital transformation by five years [1], and global healthcare budgets reflect this in their apportioning of spend to digital-related improvements. The European Union’s EU4Health 2021-2027 budget, for example, allocates €5.3

Pharma 52

Pharma Healthcare Healthcare Patients 52

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Technology

FEBRUARY 6, 2023

A Pliant spokesperson said, “This successful transaction, along with existing cash, cash equivalents, loan agreement and short-term investments, provides for operations to be funded to mid-2027, a year past the expected IPF Phase 2b clinical trial readout.” The company said a Phase IIb trial initiation should be expected in mid-2023.

Marketing 59

Marketing Pharmaceutical FDA Prospecting 59

World of DTC Marketing

APRIL 12, 2022

healthcare system is bedeviled by greed, with drug companies, device manufacturers, hospital organizations, physician groups, and insurers scrambling to grab a slice of the more than $3 trillion we spend on medical care each year. spends far more than most of the world on healthcare but receives only middling outcomes by OECD standards.

Healthcare 209

Healthcare Healthcare Insurance Physicians 209

Clarivate

AUGUST 20, 2024

In 2025, CMS will select another 15 Part D drugs for negotiations that will take effect in 2027. Although the initial set of drugs included for negotiations was limited to ten, the scope of this program will expand over time.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

World of DTC Marketing

JULY 28, 2022

Late last year, the Senate Finance Committee released draft legislation enabling Medicare negotiation for up to 10 drugs in 2025, 15 in 2026 and 2027, and 20 in 2028 and beyond. Consequently, drug companies can set prices as high as the market will bear, meaning the government has no choice but to cover many medications at unfair prices.

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256